MedPath

ICAHN School of Medicine At Mount Sinai

ICAHN School of Medicine At Mount Sinai logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
1963-01-01
Employees
5K
Market Cap
-
Website
http://www.mssm.edu

Metabolic Diet for Relapse Prevention in Anorexia Nervosa

Not Applicable
Recruiting
Conditions
Anorexia Nervosa
Interventions
Dietary Supplement: Metabolic Diet
First Posted Date
2022-01-19
Last Posted Date
2024-05-31
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
20
Registration Number
NCT05197309
Locations
🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

Rapid Sequencing of Approved Therapies in Patients with Metastatic or Unresectable Clear Cell Renal Cell Carcinoma

Early Phase 1
Recruiting
Conditions
Renal Cell Carcinoma
Interventions
First Posted Date
2022-01-12
Last Posted Date
2024-11-06
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
20
Registration Number
NCT05188118
Locations
🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

A Controlled Trial of Growth Hormone in Phelan-McDermid Syndrome and Idiopathic Autism

Phase 2
Conditions
Autism Spectrum Disorder (ASD)
Phelan-McDermid Syndrome
Interventions
First Posted Date
2022-01-11
Last Posted Date
2024-05-10
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
45
Registration Number
NCT05187377
Locations
🇺🇸

Seaver Autism Center for Research & Treatment, New York, New York, United States

Sensation, Motion, and Quality of Life on Natalizumab and Off Natalizumab

Not Applicable
Withdrawn
Conditions
Relapsing-remitting Multiple Sclerosis (RRMS)
Interventions
Device: BeCare application
First Posted Date
2021-12-29
Last Posted Date
2022-11-25
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Registration Number
NCT05172466
Locations
🇺🇸

Mount Sinai Hospital, New York, New York, United States

Environmental Factors and Thyroid Cancer

Recruiting
Conditions
Thyroid Cancer
First Posted Date
2021-12-29
Last Posted Date
2024-08-19
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
500
Registration Number
NCT05172921
Locations
🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

Connectomic Deep Brain Stimulation for Obsessive Compulsive Disorder

Not Applicable
Suspended
Conditions
Obsessive Compulsive Disorder (OCD)
Interventions
Device: Selective focal stimulation of ALIC-pathways
First Posted Date
2021-12-16
Last Posted Date
2024-08-16
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
20
Registration Number
NCT05160129
Locations
🇺🇸

Mount Sinai West, New York, New York, United States

ERTU-SODIUM: Study on the Effects of Ertugliflozin on Sodium Storage, Interstitial Volume, and Plasma Volume in HFrEF

Phase 4
Recruiting
Conditions
Congestion
Heart Failure With Reduced Ejection Fraction
Interventions
Drug: Ertugliflozin
Drug: Placebo
First Posted Date
2021-12-10
Last Posted Date
2023-10-13
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
28
Registration Number
NCT05152940
Locations
🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

Gondola Mechanism of Action

Not Applicable
Withdrawn
Conditions
Chronic Stroke
Cerebral Palsy
Parkinson's Disease
Interventions
Device: Gondola AMPS
First Posted Date
2021-12-07
Last Posted Date
2023-01-18
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Registration Number
NCT05146648
Locations
🇺🇸

Abilities Research Center, New York, New York, United States

Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials

Not Applicable
Recruiting
Conditions
Breast Cancer
Prostate Cancer
Liver Cancer
Interventions
Behavioral: Match-list intervention
Behavioral: Clinical trial match-list
First Posted Date
2021-12-06
Last Posted Date
2024-01-05
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
1200
Registration Number
NCT05146297
Locations
🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

🇺🇸

Albert Einstein College of Medicine, Bronx, New York, United States

🇺🇸

Herbert Irving Comprehensive Cancer Care Center, New York, New York, United States

Mehran 2.0 Risk Score for Prediction of CA-AKI After PCI

Completed
Conditions
Contrast-induced Nephropathy
Interventions
Procedure: Percutaneous Coronary Intervention
First Posted Date
2021-11-24
Last Posted Date
2021-11-24
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
14616
Registration Number
NCT05132062
Locations
🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath